$GOVX
GeoVax Labs, Inc.

2015 Q2 Form 10-Q Financial Statement

#000143774915014680 Filed on August 04, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $71.47K $180.4K
YoY Change -60.39% -59.14%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $360.0K $340.0K
YoY Change 5.88% -19.05%
% of Gross Profit
Research & Development $384.7K $516.2K
YoY Change -25.48% -6.15%
% of Gross Profit
Depreciation & Amortization $0.00 $10.00K
YoY Change -100.0% -50.0%
% of Gross Profit
Operating Expenses $749.5K $861.1K
YoY Change -12.95% -11.23%
Operating Profit -$678.1K -$680.6K
YoY Change -0.38%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$680.0K -$680.0K
YoY Change 0.0% 28.3%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$676.2K -$679.5K
YoY Change -0.49% 29.12%
Net Earnings / Revenue -946.08% -376.6%
Basic Earnings Per Share -$0.02 -$0.03
Diluted Earnings Per Share -$423.3B -$542.0B
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.480M $1.370M
YoY Change 81.02% -27.13%
Cash & Equivalents $2.476M $1.372M
Short-Term Investments
Other Short-Term Assets $40.00K $30.00K
YoY Change 33.33% 0.0%
Inventory
Prepaid Expenses
Receivables $40.00K $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.555M $1.400M
YoY Change 82.49% -28.21%
LONG-TERM ASSETS
Property, Plant & Equipment $98.08K $100.0K
YoY Change -1.92% 42.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.00K $10.00K
YoY Change 0.0% 0.0%
Total Long-Term Assets $109.1K $120.0K
YoY Change -9.1% 33.33%
TOTAL ASSETS
Total Short-Term Assets $2.555M $1.400M
Total Long-Term Assets $109.1K $120.0K
Total Assets $2.664M $1.520M
YoY Change 75.26% -25.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $111.0K $120.0K
YoY Change -7.47% 200.0%
Accrued Expenses $13.00K $10.00K
YoY Change 30.0% -88.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $181.1K $240.0K
YoY Change -24.55% 60.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $181.1K $240.0K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $180.0K $240.0K
YoY Change -25.0% 60.0%
SHAREHOLDERS EQUITY
Retained Earnings -$31.16M
YoY Change
Common Stock $32.59M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.483M $1.280M
YoY Change
Total Liabilities & Shareholders Equity $2.664M $1.520M
YoY Change 75.26% -25.49%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$676.2K -$679.5K
YoY Change -0.49% 29.12%
Depreciation, Depletion And Amortization $0.00 $10.00K
YoY Change -100.0% -50.0%
Cash From Operating Activities -$670.0K -$630.0K
YoY Change 6.35% 36.96%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$10.00K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -670.0K -630.0K
Cash From Investing Activities 0.000 -10.00K
Cash From Financing Activities 0.000 0.000
Net Change In Cash -670.0K -640.0K
YoY Change 4.69% -633.33%
FREE CASH FLOW
Cash From Operating Activities -$670.0K -$630.0K
Capital Expenditures $0.00 -$10.00K
Free Cash Flow -$670.0K -$620.0K
YoY Change 8.06% 34.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 govx Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
39775491
CY2015Q2 govx Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercisable
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercisable
0.21
CY2015Q2 govx Number Of Successive Renewal Options
NumberOfSuccessiveRenewalOptions
2
CY2015Q2 govx Unused Grant Funds
UnusedGrantFunds
353652
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
111041
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
55616
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52490
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
572170
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
557703
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32553227
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
30823769
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
86773
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
164560
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
79000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12800000
CY2015Q2 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
8400
CY2015Q2 us-gaap Assets
Assets
2664006
CY2014Q4 us-gaap Assets
Assets
1333198
CY2015Q2 us-gaap Assets Current
AssetsCurrent
2554920
CY2014Q4 us-gaap Assets Current
AssetsCurrent
1225495
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1101651
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2513861
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2475726
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1371802
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1374075
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1142059
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.66
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.20
CY2015Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
49999998
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5108826
CY2015Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
56442157
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
79052160
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
73046
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31950813
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31950813
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31950813
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31950813
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
31951
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
31951
CY2015Q2 us-gaap Deposits Assets
DepositsAssets
11010
CY2014Q4 us-gaap Deposits Assets
DepositsAssets
11010
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14467
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32744
CY2015Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
57048
CY2014Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
78917
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
364889
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
344862
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
766330
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
716664
CY2015Q2 us-gaap Grants Receivable
GrantsReceivable
39300
CY2014Q4 us-gaap Grants Receivable
GrantsReceivable
79341
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5934
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-74855
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4609
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-14408
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-40041
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-140909
CY2015Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1865
CY2014Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1086
us-gaap Investment Income Interest
InvestmentIncomeInterest
3057
us-gaap Investment Income Interest
InvestmentIncomeInterest
2490
us-gaap Lessee Leasing Arrangements Operating Leases Renewal Term
LesseeLeasingArrangementsOperatingLeasesRenewalTerm
P1Y
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2664006
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1333198
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
181089
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
187023
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2679809
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15850
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11164
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1289884
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1130895
us-gaap Net Income Loss
NetIncomeLoss
-1376657
us-gaap Net Income Loss
NetIncomeLoss
-1295455
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-676203
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-679537
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
749542
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
861064
us-gaap Operating Expenses
OperatingExpenses
1554612
us-gaap Operating Expenses
OperatingExpenses
1635726
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-678068
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-680623
us-gaap Operating Income Loss
OperatingIncomeLoss
-1379714
us-gaap Operating Income Loss
OperatingIncomeLoss
-1297945
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15850
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11164
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
39894
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
44503
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
2679809
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
670246
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
654396
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
98076
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
96693
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
384653
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
516202
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
788282
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
919062
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31162297
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29785640
CY2015Q2 us-gaap Revenue From Grants
RevenueFromGrants
71474
CY2014Q2 us-gaap Revenue From Grants
RevenueFromGrants
180441
us-gaap Revenue From Grants
RevenueFromGrants
174898
us-gaap Revenue From Grants
RevenueFromGrants
337781
us-gaap Share Based Compensation
ShareBasedCompensation
33590
us-gaap Share Based Compensation
ShareBasedCompensation
51354
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
756094
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.25
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
32000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.94
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
26400
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1183100
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1177500
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.50
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.49
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.15
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
2482917
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
1146175
CY2015Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
115300
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31950813
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25075729
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31950813
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24921376

Files In Submission

Name View Source Status
0001437749-15-014680-index-headers.html Edgar Link pending
0001437749-15-014680-index.html Edgar Link pending
0001437749-15-014680.txt Edgar Link pending
0001437749-15-014680-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
govx-20150630.xml Edgar Link completed
govx-20150630.xsd Edgar Link pending
govx-20150630_cal.xml Edgar Link unprocessable
govx-20150630_def.xml Edgar Link unprocessable
govx-20150630_lab.xml Edgar Link unprocessable
govx-20150630_pre.xml Edgar Link unprocessable
govx20150630_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending